Robert Gagnon

Mr. Robert E.
Gagnon is a Chief Financial & Accounting Officer at Opus Genetics, Inc., an Independent Director at Harvard Bioscience, Inc., an Independent Director at Bone Biologics Corp., an Independent Director at Purple Biotech Ltd. and a Secretary, Treasurer & Director at KD Scientific, Inc. He is on the Board of Directors at Harvard Bioscience, Inc., Bone Biologics Corp., Purple Biotech Ltd. and KD Scientific, Inc. Mr. Gagnon was previously employed as a Chief Financial Officer by Remix Therapeutics, Inc., a Partner by Gurnet Point Capital LLC, a Chief Financial & Business Officer by Verastem, Inc., a Chief Financial Officer by Harvard Bioscience, Inc., a Manager-Research & Development by Zimmer Biomet, Inc., a Chief Financial Officer, Treasurer & Executive VP by Clean Harbors, Inc., and a CAO, VP-Business Planning & Controller by Biogen Idec, Inc. He also served on the board at Verastem, Inc. He received his undergraduate degree from Bentley University and an MBA from MIT Sloan School of Management.